The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter real-world study of trastuzumab combined with pirotinib or pertuzumab as a neoadjuvant therapy for stage II-III HER-2 positive breast cancer.
 
Yuqin Zhou
No Relationships to Disclose
 
Guozhi Zhang
No Relationships to Disclose
 
Shujuan Ma
No Relationships to Disclose
 
Qiyun Shi
No Relationships to Disclose
 
Andi Wan
No Relationships to Disclose
 
Linjun Fan
No Relationships to Disclose
 
Peng Tang
No Relationships to Disclose
 
Li Chen
No Relationships to Disclose
 
Shushu Wang
No Relationships to Disclose
 
Jun Jiang
No Relationships to Disclose
 
Yi Zhang
No Relationships to Disclose
 
Xiaowei Qi
No Relationships to Disclose
 
Qiao Cheng
No Relationships to Disclose
 
Wenbin Zhou
No Relationships to Disclose
 
Ya Wei
No Relationships to Disclose
 
Maoshan Chen
No Relationships to Disclose
 
Mengyuan Wang
No Relationships to Disclose
 
Shouman Wang
No Relationships to Disclose
 
Liang Xu
No Relationships to Disclose
 
Guiying Xu
No Relationships to Disclose